Gee JM - Search Results

1

Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.

Law JH, Habibi G, Hu K, Masoudi H, Wang MY, Stratford AL, Park E, Gee JM, Finlay P, Jones HE, Nicholson RI, Carboni J, Gottardis M, Pollak M, Dunn SE. Law JH, et al. Among authors: gee jm. Cancer Res. 2008 Dec 15;68(24):10238-46. doi: 10.1158/0008-5472.CAN-08-2755. Cancer Res. 2008. PMID: 19074892

2

Estrogen deprivation in breast cancer. Clinical, experimental, and biological aspects.

Nicholson RI, Walker KJ, Bouzubar N, Wills RJ, Gee JM, Rushmere NK, Davies P. Nicholson RI, et al. Among authors: gee jm. Ann N Y Acad Sci. 1990;595:316-27. doi: 10.1111/j.1749-6632.1990.tb34305.x. Ann N Y Acad Sci. 1990. PMID: 2142873

3

Actions of oestrogens and antioestrogens on rat mammary gland development: relevance to breast cancer prevention.

Nicholson RI, Gotting KE, Gee J, Walker KJ. Nicholson RI, et al. J Steroid Biochem. 1988;30(1-6):95-103. doi: 10.1016/0022-4731(88)90081-7. J Steroid Biochem. 1988. PMID: 3386282

4

Responses to pure antiestrogens (ICI 164384, ICI 182780) in estrogen-sensitive and -resistant experimental and clinical breast cancer.

Nicholson RI, Gee JM, Manning DL, Wakeling AE, Montano MM, Katzenellenbogen BS. Nicholson RI, et al. Among authors: gee jm. Ann N Y Acad Sci. 1995 Jun 12;761:148-63. doi: 10.1111/j.1749-6632.1995.tb31376.x. Ann N Y Acad Sci. 1995. PMID: 7625718 Review. No abstract available.

5

Immunocytochemical localization of Fos protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy.

Gee JM, Ellis IO, Robertson JF, Willsher P, McClelland RA, Hewitt KN, Blamey RW, Nicholson RI. Gee JM, et al. Int J Cancer. 1995 Aug 22;64(4):269-73. doi: 10.1002/ijc.2910640410. Int J Cancer. 1995. PMID: 7657391

6

Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy.

Nicholson RI, McClelland RA, Gee JM, Manning DL, Cannon P, Robertson JF, Ellis IO, Blamey RW. Nicholson RI, et al. Among authors: gee jm. Breast Cancer Res Treat. 1994 Jan;29(1):117-25. doi: 10.1007/BF00666187. Breast Cancer Res Treat. 1994. PMID: 7912565 Clinical Trial.

7

Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy.

Gee JM, Robertson JF, Ellis IO, Willsher P, McClelland RA, Hoyle HB, Kyme SR, Finlay P, Blamey RW, Nicholson RI. Gee JM, et al. Int J Cancer. 1994 Dec 1;59(5):619-28. doi: 10.1002/ijc.2910590508. Int J Cancer. 1994. PMID: 7960234

8

Transforming growth factor-alpha and endocrine sensitivity in breast cancer.

Nicholson RI, McClelland RA, Gee JM, Manning DL, Cannon P, Robertson JF, Ellis IO, Blamey RW. Nicholson RI, et al. Among authors: gee jm. Cancer Res. 1994 Apr 1;54(7):1684-9. Cancer Res. 1994. PMID: 8137282

9

Dual immunocytochemical analysis of oestrogen and epidermal growth factor receptors in human breast cancer.

Sharma AK, Horgan K, Douglas-Jones A, McClelland R, Gee J, Nicholson R. Sharma AK, et al. Br J Cancer. 1994 Jun;69(6):1032-7. doi: 10.1038/bjc.1994.203. Br J Cancer. 1994. PMID: 8198966 Free PMC article.

10

The role of four oestrogen-responsive genes, pLIV1, pS2, pSYD3 and pSYD8, in predicting responsiveness to endocrine therapy in primary breast cancer.

Manning DL, McClelland RA, Gee JM, Chan CM, Green CD, Blamey RW, Nicholson RI. Manning DL, et al. Among authors: gee jm. Eur J Cancer. 1993;29A(10):1462-8. doi: 10.1016/0959-8049(93)90021-7. Eur J Cancer. 1993. PMID: 8398276

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters